Blood Cancer Information

In this section you will find disease specific information on the main types of blood cancers and allied blood disorders.

Leukaemia

Leukaemia is a cancer which starts in blood-forming tissue, usually the bone marrow. It leads to the over-production of abnormal white blood cells, the part of the immune system which defends the body against infection.

Signs and symptoms of leukaemia

Leukaemia can be hard to spot because the signs and symptoms are common to other unrelated illnesses. Knowing what to look out for could help you make the decision to visit your GP sooner for a blood test.

Leukaemia Myths

There are many myths about leukaemia. Get yourself clued up with the following guide

Lymphoma

Lymphoma is cancer that starts in the lymph glands or other organs of the lymphatic system. The lymphatic system is a network of fine vessels, glands and channels which occur throughout the body.

Myeloma

Myeloma, also known as multiple myeloma, is a cancer of the bone marrow which affects the plasma cells, a type of blood cell.

Aplastic Anaemia

Aplastic anaemia (AA) is a rare condition in which the bone marrow fails produce all three major types of blood cell. It is not a form of cancer.

Myeloproliferative neoplasms (MPN)

Myeloproliferative neoplasms, also known as myeloproliferative disorders (MPDs) are a group of conditions that are closely related to leukaemia.

Myelodysplastic syndromes (MDS)

Myelodysplastic syndromes (MDS) are a group of diseases where the production of blood cells by the bone marrow is disrupted.

Left to #WatchWaitWorry – Take action and contact your elected representative

We’ve created an automated form that sends an email to your elected representative asking them to consider our recommendations to improve the Watch and Watch period – all you need to do is fill in your name, email address and postcode below. It’s that simple!

Read More

Take a Moment to Catch Up

View our latest news and blog articles

October 31st

October Fundraising: Highlighting our community

With spooky season in full effect, we want to share some of the fang-tastic fundraising you have done this October in support of those living with Leukaemia....

October 20th

Leukaemia Care successfully campaigns for nationwide access to new chronic lymphocytic leukaemia treatment

The National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) have announced the approval of zanubrutinib on the NHS for patients with chronic lymphocytic leukaemia (CLL) in all nations of the UK....

October 9th

Leukaemia Care successfully campaigns for a new treatment for patients with cytomegalovirus (CMV) in Scotland

Today, the Scottish Medicines Consortium (SMC) has announced the approval of maribavir (Livtencity), a new medicine for adults with a post-transplant CMV infection that is resistant to current treatments. ...